1. Quality control of biologicals produced by recombinant DNA techniques (1983) Bulletin of the World Health Organisation 61/6: 897–911
2. Points to consider in the production and testing of new drugs and biologicals by recombinant DNA technology (1985) Office of Biologics Research and Review, Center for Drugs and Biologics, FDA
3. Control of production, pre-clinical toxicology and phase I trials of anti-tumour anti bodies and drug-antibody conjugates (1986) CRC/NIBSC, Br J Cancer 54: 557–568
4. Points to consider in the manufacture and testing of monoclonal antibody products for human use (1987) Office of Biologies Research and Review, Center for Drugs and Biologies, FDA
5. Cells-Products-Safety (1987) Dev Biol Stand 68